As a new study spotlights a growing role for LRRK2 in Parkinson’s, Denali clears an early trial hurdle

Hard on the heels of new research that points to a much wider role for LRRK2 in Parkinson’s disease than had earlier been believed, investigators at Denali say they were able to nail down some hard — though still very early — clinical data to back up their lead effort in the field.